High Resolution Genome-Wide Array-Based Comparative Genome Hybridization Reveals Cryptic Chromosome Changes in AML and MDS Cases with Trisomy 8 as the Sole Cytogenetic Aberration.
暂无分享,去创建一个
[1] D. Pinkel,et al. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. , 2005, Blood.
[2] M. Shipitsin,et al. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. , 2005, Cancer cell.
[3] M. Qumsiyeh,et al. Rapid array‐based genomic characterization of a subtle structural abnormality: A patient with psychosis and der(18)t(5;18)(p14.1;p11.23) , 2005, American journal of medical genetics. Part A.
[4] C. Preudhomme,et al. CEBPA point mutations in hematological malignancies , 2005, Leukemia.
[5] W. Hiddemann,et al. Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q , 2005, Leukemia.
[6] Adanma Ndubuizu,et al. The ALX Src Homology 2 Domain Is Both Necessary and Sufficient to Inhibit T Cell receptor/CD28-mediated Up-regulation of RE/AP* , 2004, Journal of Biological Chemistry.
[7] Kenny Q. Ye,et al. Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.
[8] N. Nowak,et al. Application of bacterial artificial chromosome array-based comparative genomic hybridization and spectral karyotyping to the analysis of glioblastoma multiforme. , 2004, Cancer genetics and cytogenetics.
[9] J. Veltman,et al. Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines. , 2004, Cancer research.
[10] D. Gary Gilliland,et al. The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management , 2004 .
[11] T. Kyo,et al. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. , 2004, Blood.
[12] Bradley P. Coe,et al. A tiling resolution DNA microarray with complete coverage of the human genome , 2004, Nature Genetics.
[13] Sarah Barber,et al. A set of BAC clones spanning the human genome. , 2004, Nucleic acids research.
[14] T. Liehr,et al. Trisomy 8 as the sole chromosomal aberration in myelocytic malignancies: a comprehensive molecular cytogenetic analysis reveals no cryptic aberrations. , 2003, Cancer genetics and cytogenetics.
[15] Jaakko Astola,et al. CGH-Plotter: MATLAB toolbox for CGH-data analysis , 2003, Bioinform..
[16] I. Hanamura,et al. Inactivation of the E3/LAPTm5 gene by chromosomal rearrangement and DNA methylation in human multiple myeloma , 2003, Leukemia.
[17] H. Tanke,et al. Trisomy 8 as the sole chromosomal aberration in myelocytic malignancies: a multicolor and locus-specific fluorescence in situ hybridization study. , 2003, Cancer genetics and cytogenetics.
[18] A. Venditti,et al. Comparison between conventional banding analysis and FISH screening with an AML-specific set of probes in 260 patients. , 2003, The hematology journal : the official journal of the European Haematology Association.
[19] S. Gruvberger,et al. BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data , 2002, Genome Biology.
[20] H. Gundacker,et al. Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study. , 2002, Blood.
[21] K. Anderson,et al. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. , 2002, Blood.
[22] S. Dudoit,et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.
[23] F. Locatelli,et al. Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15–20% of cases , 2002, Genes, chromosomes & cancer.
[24] B. Johansson,et al. The incidence of trisomy 8 as a sole chromosomal aberration in myeloid malignancies varies in relation to gender, age, prior iatrogenic genotoxic exposure, and morphology. , 2001, Cancer genetics and cytogenetics.
[25] A. Genevière,et al. A new subfamily of high molecular mass CDC2-related kinases with PITAI/VRE motifs. , 2000, Biochemical and biophysical research communications.
[26] B. Johansson,et al. Acute myeloid leukemia and clonal chromosome aberrations in relation to past exposure to organic solvents. , 2000, Scandinavian journal of work, environment & health.
[27] Cervera,et al. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes , 2000, British journal of haematology.
[28] K Wheatley,et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.
[29] W. Kuo,et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.
[30] M. Höglund,et al. Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities , 1997, Genes, chromosomes & cancer.